2 studies found for:    CP20-0903
Show Display Options
Rank Status Study
1 Active, not recruiting Study of IMC-18F1 or Ramucirumab DP in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients
Condition: Breast Cancer
Interventions: Biological: Ramucirumab DP;   Biological: IMC-18F1;   Drug: Capecitabine
2 Recruiting Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Tetrathiomolybdate

Indicates status has not been verified in more than two years